MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Pancreas, Pancreatic
Bluestar Genomics
Attachments
www.bluestargenomics
Parents
*Industry: San Diego, California
*Industry: San Francisco, California
2021: Liquid biopsies dominate FDA's latest breakthrough device nods
Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Pancreas, Pancreatic
Architects: Diagnostics_Liquid Biopsy
FDA _ Breakthrough Devices Program
Children
Founded 2016
Noninvasive pancreatic cancer detection test for use in patients with new-onset diabetes.
San Diego, California
San Francisco, California
The test analyzes blood samples for signs of an abnormal epigenomic and genomic signature associated with pancreatic cancer, specifically for methyl-cytosine oxidation of 5-hydroxymethylcytosine (5hmC).